Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 65.9 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 102 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 106 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 115 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 53.8 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 79.2 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 95.3 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 88.8 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 0.0 | BCD100427B001 | 29 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 0.5 | BCD100427B003 | 28.4 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 1.0 | BCD100427B007 | 109 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 2.0 | BCD100427B011 | 191 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 4.0 | BCD100427B015 | 35.3 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 8.0 | BCD100427B019 | 218 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 12.0 | BCD100427B023 | 87.1 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 24.0 | BCD100427B027 | 119 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 258 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 187 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 81.9 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 86.6 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 108 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 133 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 128 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 0.5 | BCD100427B004 | 19.4 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 1.0 | BCD100427B008 | 57.3 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 2.0 | BCD100427B012 | 171 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 4.0 | BCD100427B016 | 43.5 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 8.0 | BCD100427B020 | 104 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 12.0 | BCD100427B024 | 150 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 24.0 | BCD100427B028 | 83.7 | pmol/sample |